[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@BIOTECHBATMAN Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::955983797543161857.png) @BIOTECHBATMAN BIOTECH BATMAN

BIOTECH BATMAN posts on X about $ions, $arwr, $alny, superior the most. They currently have XXX followers and X posts still getting attention that total X engagements in the last XX hours.

### Engagements: X [#](/creator/twitter::955983797543161857/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::955983797543161857/c:line/m:interactions.svg)

- X Week XXX -XX%
- X Month XXXXX +143%
- X Months XXXXX +1,648%
- X Year XXXXX +194%

### Mentions: X [#](/creator/twitter::955983797543161857/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::955983797543161857/c:line/m:posts_active.svg)

- X Week X -XX%
- X Month X +167%
- X Months X +300%
- X Year XX +67%

### Followers: XXX [#](/creator/twitter::955983797543161857/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::955983797543161857/c:line/m:followers.svg)

- X Week XXX -XXXX%
- X Month XXX +0.52%
- X Months XXX -XXXX%
- X Year XXX -XXXX%

### CreatorRank: undefined [#](/creator/twitter::955983797543161857/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::955983797543161857/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::955983797543161857/influence)
---

**Social category influence**
[stocks](/list/stocks)  XXXXX%

**Social topic influence**
[$ions](/topic/$ions) 66.67%, [$arwr](/topic/$arwr) 66.67%, [$alny](/topic/$alny) 66.67%, [superior](/topic/superior) XXXXX%

**Top assets mentioned**
[Ionis Pharmaceuticals, Inc. Common Stock (IONS)](/topic/$ions) [Arrowhead Research Corporation (ARWR)](/topic/$arwr) [Alnylam Pharmaceuticals, Inc. (ALNY)](/topic/$alny)
### Top Social Posts [#](/creator/twitter::955983797543161857/posts)
---
Top posts by engagements in the last XX hours

"Ioniss first siRNA clinical trial well underway and already has positive data. Target is apoC-III for biannual dosing. This seems strategic designed to kill any advantage a competitor may have taking the fast follower strategy. $ions $alny $arwr"  
[X Link](https://x.com/BIOTECHBATMAN/status/1975547425038422076) [@BIOTECHBATMAN](/creator/x/BIOTECHBATMAN) 2025-10-07T13:03Z XXX followers, XXX engagements


"Ionis will come after you in the market through pricing of their first-in-class drug and their follow-on drugs superior to your offerings. AND they will vigorously defend their IP/targets in court. The fast follower strategy will be economically unviable. $ions $alny $arwr"  
[X Link](https://x.com/BIOTECHBATMAN/status/1975547426867192320) [@BIOTECHBATMAN](/creator/x/BIOTECHBATMAN) 2025-10-07T13:03Z XXX followers, XXX engagements